Pityriasis rubra pilaris: a review of diagnosis and treatment.
Pityriasis rubra pilaris (PRP) is a rare inflammatory dermatosis of unknown etiology, and finding a successful therapy can be challenging. PRP occurs equally in men and women. In some patients, associated autoimmune diseases, infections, or malignancies are possible trigger factors. PRP shows a bimodal age distribution, peaking in the first as well as in the fifth to sixth decade. Its classification into five subgroups is based on age at onset, clinical course, morphologic features, and prognosis. More than 50% of patients are best classified as type I with adult-onset PRP. This form is also characterized by high spontaneous remission rates (80%) within 1-3 years. Clinically, the classical adult (type I) and classical juvenile (type III) forms appear to be the same except for the patient's age. Recently, the designation of a new category of PRP (type VI) has been proposed that is characterized by the presence of HIV infection with different clinical features and a poorer prognosis. Typical morphologic features of PRP are erythematosquamous salmon-colored plaques with well demarcated islands of unaffected skin. Often, keratoderma of the palms and soles is present. In patients with extensive disease, ectropion is a dreaded complication. Histology shows hyperkeratosis, alternating orthokeratosis and parakeratosis in a checkerboard pattern, and focal acantholytic dyskeratosis. Descriptions and therapeutic experiences are mainly based on case reports. Mostly, systemic retinoids, methotrexate, and other immunosuppressive agents as well as UV light therapy are applied, with varying response rates. In recent years, treatment with so-called 'biologics' is becoming more and more popular for treating recalcitrant PRP. We present a review of the clinical features, histopathologic findings, classification, differential diagnoses, and treatment of PRP.
Klein
Annette
A
Department of Dermatology, University of Regensburg, Regensburg, Germany. annette.klein@klinik.uni-regensburg.de
Landthaler
Michael
M
Karrer
Sigrid
S
D000287:Administration, Topical; D001706:Biopsy; D003879:Dermatologic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D010916:Pityriasis Rubra Pilaris / Q000145:classification / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D012867:Skin / Q000473:pathology
D003879:Dermatologic Agents